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Currently, the majority of diagnoses of malaria rely on a combination of the patient’s clinical presentation and
the visualization of parasites on a stained blood film. Breath offers an attractive alternative to blood as the basis
for simple, noninvasive diagnosis of infectious diseases. In this study, breath samples were collected from indi-
viduals during controlled malaria to determine whether specific malaria-associated volatiles could be detected
in breath. We identified 9 compounds whose concentrations varied significantly over the course of malaria: car-
bon dioxide, isoprene, acetone, benzene, cyclohexanone, and 4 thioethers. The latter group, consisting of allyl
methyl sulfide, 1-methylthio-propane, (Z)-1-methylthio-1-propene, and (E)-1-methylthio-1-propene, had not
previously been associated with any disease or condition. Before the availability of antimalarial drug treatment,
there was evidence of concurrent 48-hour cyclical changes in the levels of both thioethers and parasitemia. When
thioether concentrations were subjected to a phase shift of 24 hours, a direct correlation between the parasitemia
and volatile levels was revealed. Volatile levels declined monotonically approximately 6.5 hours after initial drug
treatment, correlating with clearance of parasitemia. No thioethers were detected in in vitro cultures of Plasmo-
dium falciparum. The metabolic origin of the thioethers is not known, but results suggest that interplay between
host and parasite metabolic pathways is involved in the production of these thioethers.
Keywords. malaria; (E)-1-methylthio-1-propene; thioethers; volatile organic compound; odors; machine learn-
ing; diagnostic tool.
Globally, an estimated 3.2 billion people in 97 countries
are at risk of malaria [1], and in 2013, an estimated 198
million cases and 584 000 deaths were attributed to this
infection [1]. Accurate diagnosis of malaria is important
to provide adequate treatment, conserve valuable drugs,
and help prevent the emergence of resistant strains of ma-
laria parasites [2]. However, diagnosis continues to pre-
sent challenges. Currently, the majority of diagnoses
rely on a combination of clinical presentation and the cen-
tury-old approach of visualizing parasites on a stained
blood film. Approximately 197 million blood films were
examined for malaria parasites in 2013 [1], and blood
film examination is still considered the diagnostic gold
standard. However, the method’s accuracy depends on
the skill of the operator and the use of well-maintained
equipment, and low levels of parasitemia can be challeng-
ing to detect. Rapid diagnostic tests represent a convenient
point-of-care platform but suffer from suboptimal sensi-
tivity in some settings [2].There remains a need for a sim-
ple, inexpensive, and reliable diagnostic test for malaria
that can be performed in the homes of patients or in
other primary healthcare settings in remote areas [2].
Human breath offers an attractive alternative as the
basis for simple, noninvasive diagnosis of infectious dis-
eases. The breath of a healthy human contains up to
1849 volatile organic compounds (VOCs) [3]. In addi-
tion, there is evidence that the breath of infected people
may contain VOCs indicative of specific diseases [4–6].
For example, some of the unique VOCs found in the
headspace of Mycobacterium tuberculosis cultures
have also been found in the breath of patients with
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tuberculosis [6]. Identification of such VOC biomarkers is an
important step toward developing breath-based diagnostic
methods. In the case of malaria, a range of intriguing reports
suggests that humans [7, 8] and laboratory animals [9] infected
with malaria parasites have elevated attractiveness to mosqui-
toes. Chemical cues have been hypothesized to drive at least
some of the increased levels of attractiveness, but, so far, specific
compounds have only been identified in a mouse model [9] and
have not been found associated with malaria in humans [7, 8].A
study of blood cultures of Plasmodium falciparum did not reveal
any VOCs associated with the presence of the parasite [10]. In-
depth examination of the VOC profile of patients with malaria
is ideal because it is possible that, unlike the situation with tu-
berculosis, specific VOC evolution may be affected by metabolic
interactions between the parasite and the human host. However,
this had not been done previously because breath is ephemeral
and naturally acquired malaria largely occurs in locations re-
mote from state-of-the-art analytical instrumentation.
In this research, breath samples were collected during con-
trolled human malaria studies that are increasingly being used
to aid vaccine and drug development [11, 12]. The experimen-
tally induced blood-stage malaria (IBSM) paradigm uses direct
intravenous inoculation of infected erythrocytes and has been
used to investigate physiological and immunological status,
drug efficacy, vaccine efficacy, and host-pathogen interactions
in healthy, malaria-naive adults [11]. This was an ideal oppor-
tunity to test the hypothesis that malaria generates specific VOC
signatures due to the host-pathogen interaction that might be
detected by breath analysis but not in in vitro blood cultures.
In this article, we present the results of a study in which breath
samples were collected before and during early-stage malaria
and after antimalarial drug administration, to determine wheth-
er malaria-associated VOCs can be detected in breath.
METHODS
Clinical Trial
The study was conducted as previously described [12, 13] and in-
cluded 2 individual cohorts of 2 separate experimental studies
aimed to test the in vivo activity of antimalaria drugs. The anti-
malaria drug investigated in cohort 1 was OZ439, and the drug
used in cohort 2 was piperaquine. Data from these studies will be
reported separately. Written informed consent was received from
participants prior to inclusion in the study (clinical trials registra-
tion ACTRN12612000814875 and ACTRN12613000565741).
Description of the clinical trials, ethics, and polymerase chain re-
action (PCR) method for quantification of P. falciparum parasi-
temia [14] are presented in the Supplementary Materials.
Breath Analysis
Volunteers breathed through a cardboard mouthpiece connected
to a chamber. After a few seconds of breathing, the chamber was
connected to a 3-L impermeable aluminum gas bag (Shanghai
Sunrise Instrument, Shanghai, China). Volunteers were asked
to breath out a small amount, using a “ha” expiration; to
pause; and, during the pause, to put the cardboard tube between
their lips, and to continue the exhalation as far as they could,
comfortably. In this way, only the last portion of the breath (ie,
the alveolar air) was trapped in the bag. As soon as the volunteer
finished breathing out, they closed the red valve (Supplementary
Figure 1). Neither a nose clip nor a VOC filter were used. Days on
which breath samples were collected are detailed in Supplemen-
tary Table 1. Breath from the bags was transferred to a sorbent
tube, as shown in Supplementary Figure 2. Detailed description
of gas chromatography–mass spectrometry analysis of the sam-
ples can be found in the Supplementary Materials.
Machine Learning Classifications and Cross-validations
Data used in this test were the peak area of the total ion chro-
matograms of the 4 thioethers, and the classes used for classifi-
cations and cross-validation were class 1, day 0 (collected before
infection), and class 2, day 7 (collected in the afternoon; for co-
hort 1) or day 8 (collected in the afternoon; for cohort 2); these
samples were obtained after drug administration. Two com-
monly used classifiers, a support vector machine and a k nearest
neighbor algorithm [15–18], were used to train a model, using
training data, and then to classify the test samples. Full descrip-
tion of these classifiers and cross-validation can be found in the
Supplementary Materials.
Cell Culture
The 3D7 strain of P. falciparum was maintained in vitro as
described previously [19], with modifications [20]. The serum
substitute Albumax II was used instead of human serum
[21]. Experiments were set up in Sarsted, canted-neck, polysty-
rene, 175-cm2 flasks with a PE Phenolic-style cap (catalog
83.1812.001) at a hematocrit of 1% and a starting parasitemia
of 0.5%, in 100 mL of Roswell Park Memorial Institute 1640 me-
dium. Experiments were initiated with parasites in the ring stage,
except for those in which antimalarial drug or detergent were
added, which were initiated with parasites mainly in the tropho-
zoite stage. The flask headspace was flushed with a parasite-
culture gas mix [20], the lid was closed and sealed with paraffin
film, and the flask was incubated at 37°C for 96 hours with cons-
tant shaking [20]. The experiments designed to lyse the cells in
the culture flask, inhibit growth with antimalaria drugs [22,
23], and spike red blood cell (RBC) cultures with the 4 thioethers
are described in detail in the Supplementary Materials.
RESULTS
The study was conducted in 2 cohorts (n = 8 and n = 7), each of
which received a different drug treatment regimen. In cohort 1, a
single volunteer did not consent to provide breath samples,
whereas in cohort 2, a single volunteer was unable to follow the
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procedure for providing breath samples. Therefore, 7 and 6 breath
samples, respectively, were available for analysis from the 2 co-
horts. All volunteers became PCR positive on approximately
day 4 after inoculation and reached the protocol-designated treat-
ment threshold of >1000 parasites/mL, as determined by quanti-
tative PCR of morning samples collected on day 7 from cohort 1
and morning samples collected on day 8 from cohort 2. The al-
located treatment then commenced, and the volunteers were ad-
mitted to the clinic (Supplementary Table 1). The mean peak
pretreatment parasitemia levels were 4550 parasites/mL and
6218 parasites/mL for cohorts 1 and 2, respectively. The highest
level of parasitemia between the 2 cohorts was 47 536 parasites/
mL, a level that corresponds to approximately 0.001% parasitemia
and is at about the threshold of microscopic detection.
VOCs in Breath of Volunteers
Using standard gas chromatography–mass spectrometry, we
identified 9 compounds whose concentrations varied during
the malaria episode. These compounds were carbon dioxide, iso-
prene, acetone, benzene, cyclohexanone, and 4 thioethers. The
latter group was of particular interest because they have not pre-
viously been associated with any disease or condition and be-
cause their concentrations changed during infection for all
individuals from both cohorts. The 4 thioether compounds were
fully identified using commercially available and synthesized
Table 1. Putative Biomarkers of Malaria in Breath
Putative Biomarker
Retention Time,
mina
Characteristic
Ionsb
Allyl methyl sulfide 3.8–3.9 88, 73, 41
1-methylthio-propane 4.09 61, 90, 48
(E )-1-methylthio-1-propene 4.30 45, 73, 88
(Z )-1-methylthio-1-propene 4.76 45, 73, 88
a Values denote the retention time of each putative biomarker in the
chromatogram.
b Values are the 3 most-common characteristic ions for each putative
biomarker.
Figure 1. Extracted ion gas chromatograms for a mass-to-charge ratio (m/z) of 88+90 for 1 typical subject on day 0, day 4, day 7 (after drug adminis-
tration), and day 9. Peaks: 1, allyl methyl sulfide; 2, 1-methylthio-propane; 3, (E )-1-methylthio-1-propene; 4, (Z )-1-methylthio-1-propene.
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standards (Table 1) as allyl methyl sulfide, 1-methylthio-propane,
(Z )-1-methylthio-1-propene, and (E)-1-methylthio-1-propene.
These compounds have previously been reported at low levels
in the breath of healthy individuals [3].
In cohort 1 at day 0 (ie, in the sample collected just before in-
fection), thioethers were either undetectable or present at very
low levels (Figure 1). Four days after infection (ie, on day 4),
the levels of the 4 thioethers increased, on average, by a factor
of 21. Their levels reached a maximum on the day of treatment
(ie, day 7 or 8), approximately 6.5 hours after initial drug admin-
istration. For cohort 1, (Z)-1-methylthio-1-propene was the com-
pound with the largest change in intensity between day 0 and
drug administration, increasing in concentration by >100-fold.
The concentration of 1-methylthio-propane increased by 50-fold.
For cohort 2, 1-methylthio-propane and (E )-1-methylthio-
1-propene increased in concentration between day 0 and drug
administration by 90-fold and 68-fold, respectively (Figures 2
and 3). Approximately 6.5 hours after the initial drug administra-
tion, the levels of the thioethers declined rapidly (Figure 2). Sim-
ilar results were found in cohort 2 (Figure 3).
Ambient air specimens collected during both clinical trials
did not contain detectable levels of any of the thioethers, in
agreement with observations by Suarez et al [24], who found
that allyl methyl sulfide could not be detected in indoor air.
These results exclude the possibility that these chemicals were
a result of contamination of the ambient air.
In a separate study of breath samples from patients with fever
due to bacterial infection who presented to hospital emergency
departments, the thioethers were undetectable in fever and con-
trol groups, and the levels were below those observed after in-
fection in the present study (unpublished data). It appears,
therefore, that elevation of the levels of the detected thioethers
is specific to malaria, rather than to bacterial infections.
Volatile Levels in Breath Specimens Versus Parasite Levels in
Blood Specimens
We investigated the relationship between thioether levels and
parasitemia levels. Before treatment, there was evidence of cycli-
cal changes in both the levels of thioethers, particularly allyl
methyl sulfide and (E)-1-methylthio-1-propene, and, as expect-
ed, in the levels of parasitemia (Figures 2 and 3). In both cases,
the period appeared to be approximately 48 hours, although the
sampling regimen did not allow any greater resolution, and was
Figure 2. VOCs in breath (right y-axis) and parasite levels in blood (left
y-axis) for cohort 1 during the course of experimental malaria before (dur-
ing the first 7 days after infection onset) and after antimalarial treatment.
Figure 2 continued. Each participant in the cohort was inoculated on day
0 with approximately 1800 human erythrocytes infected with Plasmodium
falciparum. Breath and blood samples were collected over the course of
infection. Drug treatment (OZ439) started on day 7 for cohort 1 (n = 7),
as indicated by dotted vertical lines in the plots. Multiplication and clearance
of parasites are denoted by blue circles, and the abundance of compounds is
denoted by squares: (Z)-1-methylthio-1-propene (m/z 88), 1-methylthio-
propane (m/z 90), allyl methyl sulfide (m/z 88) and (E )-1-methylthio-1-propene
(m/z 88). Error bars represent standard errors of the mean.
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imposed on a general trend of increased parasitemia levels, as de-
termined by quantitative PCR, and increased levels of thioethers.
The cyclical variation in thioether level appeared to be out of
phase with the parasitemia. When the thioether data were sub-
jected to a phase shift of 24 hours, a direct correlation between
parasitemia and volatile levels was revealed (Figure 4A and 4B).
For cohort 1, allyl methyl sulfide and (E )-1-methylthio-1-
propene were the compounds whose levels had the highest cor-
relations with parasitemia levels, with r2 values of 0.94 and 0.97,
respectively. Also, for cohort 2, the allyl methyl sulfide concentra-
tion was highly correlated to the parasitemia level (r2 = 0.97), as
was the 1-methylthio-propane concentration (r2 = 0.92).
In both cohorts, the highest levels of thioethers were seen in
the first breath sample, collected approximately 6.5 hours after
drug administration (Figures 2 and 3), possibly indicating a role
for parasite death or lysis in driving thioether production. Vo-
latile levels declined monotonically after initial drug treatment,
correlating with clearance of parasitemia (Figures 2 and 3). For
cohort 1, administration of a fast-acting synthetic ozonide re-
sulted in a faster decline in parasitemia and thioether levels
(Figure 2), compared with the decline observed with the slow-
er-acting bisquinoline 4-aminoquinoline used in cohort 2 (Fig-
ure 3). For cohort 1, after treatment, there was a strong
correlation between levels of parasitemia and the abundance
of (Z )-1-methylthio-1-propene (r2 = 0.76), (E )-1-methylthio-
1-propene (r2 = 0.98), and 1-methylthio-propane (r2 = 0.99;
Figure 4C). For cohort 2, there was a lower but still significant
correlation between the levels of thioethers and the levels of par-
asitemia, with r2 values of > 0.79 for (E )-methylthio-1-propene
and > 0.76 for allyl methyl sulfide (Figure 4D).
Machine Learning Classification of Malaria, Based on
Thioether Levels
Machine learning methods were used to verify our observation
that changes in the levels of thioether (peak areas) are signifi-
cant between day 0 before infection and days 7 or 8 after drug
administration. As demonstrated in previous work [17, 25, 26],
different classifiers’ performance on the same data set varies;
therefore, 2 classifiers were used: a support vector machine
and a k nearest neighbor classifier. It was found, that using
leave-one-out cross-validation, all samples could be perfectly
classified on the basis of volatile levels, demonstrating statisti-
Figure 3. VOCs in breath (right y-axis) and parasite levels in blood (left
y-axis) for cohort 2 during the course of experimental malaria before (dur-
ing the first 8 days after infection onset) and after antimalarial treatment.
Figure 3 continued. Each participant in the cohort was inoculated on day
0 with approximately 1800 human erythrocytes infected with Plasmodium
falciparum. Breath and blood samples were collected over the course of
infection. Drug treatment ( piperaquine) started on day 8 for cohort 2
(n = 6), as indicated by dotted vertical lines in the plots. Multiplication
and clearance of parasites are denoted by blue circles, and the abundance
of compounds is denoted by squares: (Z)-1-methylthio-1-propene (m/z 88),
1-methylthio-propane (m/z 90), allyl methyl sulfide (m/z 88) and (E )-1-
methylthio-1-propene (m/z 88). Error bars represent standard errors of
the mean.
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cally significant differences between baseline and soon after
drug administration. After performing data normalization to
account for changes in instrument sensitivity over time, we
trained the classifiers by using the cohort 1 data, and they
were able to perfectly classify the data from cohort 2. In the
same way, using cohort 2 data to train the classifiers gave perfect
classification of cohort 1 data. This result is a strong indication
that the classification was not due to overfitting of the data.
Thioethers Were Not Detected in the Headspace of In Vitro
Blood Cultures of P. falciparum
Wong et al [10] previously reported that no change in headspace
volatile levels could be detected when an in vitro erythrocyte cul-
ture was infected with P. falciparum. We specifically searched for
the 4 thioethers in the headspace of 100 mL of a RBC suspension
(1% hematocrit; starting parasitemia level, 0.5%) cultured for 4
days without changing medium (final parasitemia level, 38.8%).
No thioethers were detected (Figure 5), and no significant changes
in the entire volatile profile of the samples, compared with our
control (noninfected blood), were observed. Thioethers were
also not detected in the headspace of P. falciparum–infected cell
cultures 5.5 hours following treatment with 1000 ng/mL of the
antimalarial piperaquine tetraphosphate tetrahydrate or after lys-
ing the cells with a combination of 0.8% saponin and 8% Triton
X-100 (final parasitemia level, 21%). As a positive control, we
spiked the 4 thioethers into the RBC cultures at the following lev-
els: 2.7 nmol/L allyl methyl sulfide and 4.4 nmol/L 1-methylthio-
propane (the same level of each was previously detected in healthy
individuals [27])and 2.5 nmol/L of each of the isomers (Z)-meth-
ylthio-1-propene and (E)-methylthio-1-propene. We then incu-
bated the sample for 4 days and collected headspace specimens
following procedures described in the Supplementary Materials.
All of the thioethers were readily detected (Figure 5). Moreover,
no thioether was detected in the ambient samples collected from
the tissue culture laboratory (data not shown).
The biomass of parasitized RBCs present in the blood cul-
tures at the end of one of the in vitro experiments (0.1 L × a he-
matocrit of 1% × a parasitemia level of 39% = 0.39 g of infected
erythrocytes) was approximately 18-fold higher than the bio-
mass of infected RBCs estimated to be present in the volunteers
Figure 4. Correlation of parasite level and abundance of malaria VOCs before (A) and after (B) antimalarial treatment of the 2 cohorts. The thioether data
were subjected to a phase shift of 24 hours, which revealed a direct correlation between parasitemia and volatile levels. In cohort 1, a fast-acting synthetic
ozonide drug was used on day 7, and in cohort 2, a slower-acting piperaquine drug was administered on day 8. Points denote means and standard
deviations.
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(5 L × a hematocrit of 43% × a parasitemia level of 0.001% =
0.02 g of infected RBCs). Even if we consider sequestered
parasites (not quantified by PCR) in the in vivo samples, the bi-
omass would not affect the calculated value by >10%, especially
considering that there is a known correlation between the se-
questered parasites and the severity of the disease [28]. Approx-
imately 200 mL of the available 400 mL of headspace was
sampled in vitro, compared with the 1 L of breath sampled
from volunteers.
DISCUSSION
Levels of 9 VOCs were found to change in the breath of volunteers
after they were infected with blood-stage malaria parasites. Of
these, acetone and isoprene are the most prominent volatile com-
pounds in the breath of healthy humans. Acetone is produced by
acetoacetate-decarboxylase during fatty acid breakdown [29].
Isoprene is a by-product of the mevalonate pathway, its concen-
tration changes during exertion, and it can be an indicator of ox-
idative stress [3, 30–32]. Benzene is believed to be an exogenous
contaminant of human breath. It is a common pollutant in the
environment [3], can partition into human fat depots, and
would have an elevated concentration during increased metabolic
activity, particularly lipolysis. Cyclohexanone has also been re-
ported previously in the breath of healthy individuals, as well as
in urine samples [3].CO2 flux is directly related to metabolic rate:
the findings by Lavoisier form the basis for capnography, a breath
test to monitor partial pressure of CO2 [29]. Of the VOCs whose
levels changed during malaria, only the levels of thioethers—allyl
methyl sulfide, (E)-1-methylthio-1-propene, (Z)-1-methylthio-1-
propene, and 1-methylthio-propane—were correlated to parasite-
mia levels.
It is believed that allyl methyl sulfide and 1-methylthio-
propane enter alveolar air from the blood, where they may
have diet- or drug-related origins [27]. Allyl methyl sulfide
has been associated with the consumption of garlic and is a me-
tabolite of allicin [24, 33]. It is important to note that, in both
cohorts, all volunteers had fasted before collection of morning
samples and that, for the afternoon samples, which were collect-
ed when volunteers were confined in the clinic, samples were
collected at least 3 hours after lunch. Lunch diets were different
in both cohorts, yet the same pattern in volatile levels was ob-
served, eliminating a possible dietary origin for the compounds.
Moreover, in another (unpublished) study, thioethers were ab-
sent from the breath of patients with bacteremia/septicemia and
controls, indicating that the thioethers are neither generic fever
markers nor general markers of infection. In the present study,
increased levels of thioethers were observed before drug admin-
istration. Thioethers could not be directly derived from the an-
timalarial drugs because neither of the drugs used in these trials
contained a sulfur atom. Furthermore, none of the components
of the parasite inoculum injected on day 0 contained thioethers.
The fact that thioethers were undetectable in the headspace
above in vitro cultures of P. falciparum was unequivocally estab-
lished. All attempts, including culturing for 2 intraerythrocytic cy-
cles (96 hours), high parasitemia levels, and using antimalarial
drug and lysing cells, failed to result in the detection of thioethers.
Of course, in vivo, other factors are relevant. For example, lipophil-
ic compounds such as the thioethers may partition into the plastic
of the cell culture flasks. However, the spiking protocol we used
mimicked the very low level of thioethers seen in the breath of
healthy people [18]. Therefore, had thioethers been present, even
at very low levels, we expect we would have detected them. In this
respect, our findings support those of Wong et al [10], who, using
culture conditions that differed slight from those in the present
study, also found no differences in the VOC profile between con-
trol RBC cultures and parasitized cultures.
Thioethers are poorly soluble in water, and, although it is
known that at least allyl methyl sulfide and 1-methylthio-propane
Figure 5. Screening of in vitro Plasmodium falciparum blood cultures
under various conditions for thioethers (m/z 88+90). Thioethers were absent
in the control (A) and in the headspace of 100 mL of a red blood cell sus-
pension (1% hematocrit; B). Thioethers were neither present following treat-
ment with 1000 ng/mL of the antimalarial piperaquine tetraphosphate
tetrahydrate (C) nor after treatment-lysing of cells (D). As a positive control,
red blood cell cultures were spiked at the levels previously detected in
healthy individuals (E ). Peaks: 1, allyl methyl sulfide; 2, 1-methylthio-
propane; 3, (E )-1-methylthio-1-propene; and 4, (Z )-1-methylthio-1-propene.
Data are representative of findings obtained in 2 independent experiments
with average parasitemia levels of 29.9%. Abbreviation: VOC, volatile organ-
ic compounds.
1126 • JID 2015:212 (1 October) • Berna et al
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/article-abstract/212/7/1120/841544 by U
niversity of W
estern Sydney Library user on 06 February 2020
reach the alveolar air from the blood in healthy individuals [27],
we do not know whether (E)-1-methylthio-1-propene and (Z)-1-
methylthio-1-propene would be detectable in the blood of infect-
ed volunteers. From a practical point of view, analysis of breath
samples would be simpler and more convenient for patients.
The cycling of thioether levels, which appears to have the
same periodicity as the 48-hour life cycle of the blood-stage par-
asite is intriguing. It suggests that thioether levels may be linked
to a specific phase in the parasite’s intraerythrocytic cycle.
Although our sampling regimen did not have the resolution
to define the association precisely, the 180° phase shift from
maximum parasitemia and the peak in thioether levels that oc-
curs shortly after drug treatment suggests that the bursting of
erythrocytes (schizont rupture) to release merozoites and infect
new RBCs [2], accompanied by the death of parasite, may be the
event that triggers maximal thioether release.
In the IBSM protocol, which involves malaria-naive volun-
teers, it is neither ethical nor safe to allow parasitemia levels
to rise to those seen in field-acquired infections in human pop-
ulations living in malaria-endemic regions, which may be 3 log
units higher at symptom onset. It will be important to deter-
mine, in clinical trials with patients who have naturally acquired
malarias, whether the same thioethers can be detected and
whether their levels correlate with the much higher parasitemia
levels expected. The fact that changes in VOC levels in infected
volunteers’ breath occurred at low parasitemia levels indicates
that analysis of breath specimens shows promise as a sensitive
method for the diagnosis of malaria in patients with levels of
parasitemia below the threshold of detection of rapid diagnostic
tests used to detect the circulating biomarker of P. falciparum
infection, PfHRP2 (<100 parasites/µL [34]).
The metabolic origin of the thioethers is unclear, and we can-
not exclude the possibility that they may originate from 1 ormore
molecules in the breath that break down or rearrange during col-
lection and analysis. However, our spiking protocols confirmed
that the thioethers detected during our analytical procedure
were stable. Our results suggest that some aspect of host response
is involved in the production of specific VOCs, possibly during or
because of schizont rupture. Just as parasite components released
during lysis of infected RBCs (schizont rupture) and phagocyto-
sis by immune cells generate the febrile response to malaria [35],
other molecular events that occur during schizont rupture could
generate the thioethers. In the absence of an in vitro model, it is
highly desirable to identify a suitable animal model of malaria
that leads to release of the same thioethers, to enable studies of
the metabolic origins of these compounds.
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